The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2022 | Insights into the HealthTree foundation
Nathan Sweeney
• 17 May 2022
Nathan Sweeney, PhD, HealthTree, Lehi, UT, shares some insights into the role of HealthTree, an organization which aims to tailor treatment approaches to patients with multiple myeloma. Dr Sweeney explains the process by which HealthTree accurately makes use of patient information to select the best treatment approaches. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.
